ReviewInternational journal of molecular sciences2019

The Potential of Combining Tubulin-Targeting Anticancer Therapeutics and Immune Therapy.

Alexis Fong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.